Exhibit 10.6


 





EXECUTIVE CHAIRMAN AGREEMENT


 


This EXECUTIVE CHAIRMAN AGREEMENT
(the “Agreement”) is entered into as of June 10, 2021, by and between Quantum-Si Incorporated, a Delaware corporation
(the “Company”), and Jonathan Rothberg, PhD. (“Dr. Rothberg”).


 


WHEREAS, on and after June 10,
2021 (the “Effective Date”), Dr. Rothberg will serve on the Board of Directors of the Company (the “Board”),
and will serve as the Executive Chairman of the Board, in each case, subject to his election by the Company’s shareholders; and


 


WHEREAS, the Company and Dr.
Rothberg desire to entire into this Agreement setting forth the terms of Dr. Rothberg’s Executive Chairman relationship with the
Company and certain other matters relating to his role.


 


NOW, THEREFORE, in consideration
of the premises and the mutual covenants and agreements herein contained, the parties hereto agree as follows:


 


1.             Consulting Services. Dr. Rothberg agrees to serve as the Executive Chairman of the Board with all the powers of the
office of the Executive Chairman as set forth in the Company’s By-Laws (in the aggregate, the “Services”). Dr. Rothberg
will be reasonably available to consult by phone, email or in person at the Company, or another mutually agreeable site with Company personnel,
and any dates for visits to the Company’s offices will be arranged by mutual agreement. The term of this Agreement will commence
on the Effective Date and continue until terminated as provided herein (the “Service Period”). Dr. Rothberg agrees
to devote that amount of time as is reasonably required by the Company for him to perform the Services, taking into account his other
business obligations as in effect from time to time. Dr. Rothberg represents that he has the qualifications, the experience and the ability
to properly perform the Services, and that he will use his best efforts to perform the Services such that the results are satisfactory
to the Company.


 


2.             Independent Contractor. Dr. Rothberg’s relationship with the Company will be that of an independent contractor
and not that of an employee. Dr. Rothberg will be solely responsible for determining the method, details and means of performing the Services.
Dr. Rothberg acknowledges and agrees that he will not be eligible for any benefits available to employees of the Company. Dr. Rothberg
will report to the Board concerning the Services performed under this Agreement. The nature and frequency of these reports will be left
to the discretion of the Board. Dr. Rothberg will have full responsibility for applicable withholding taxes for all compensation paid
to Dr. Rothberg under this Agreement, and will have full responsibility for compliance with all applicable labor and employment legal
requirements with respect to Dr. Rothberg’s self-employment. Dr. Rothberg agrees to indemnify, defend and hold the Company harmless
from any liability for, or assessment of, any claims or penalties with respect to such withholding taxes and labor or employment legal
requirements.


 






     


     


    

 


3.             Compensation and Other Benefits. 


 


(a)          Consulting
Fee. As compensation for the Services provided hereunder, during the Service Period, the Company will pay to Dr. Rothberg a Services
fee (the “Services Fee”) of (i) $33,334 per month. The Services Fee will be paid to Dr. Rothberg on the first business
day of each month during the Service Period. The Company will reimburse Dr. Rothberg for his reasonable out-of-pocket expenses incurred
in connection with the provision of the Services, pursuant to the terms and conditions of applicable Company policies and requirements.


 


(b)          Office
Space, etc. During the Service Period, the Company will provide Dr. Rothberg with reasonable office space at the Company’s
headquarters and access to secretarial and administrative assistance as needed so that he may perform his duties hereunder.


 


(c)          Equity
Awards. Dr. Rothberg’s restricted stock unit grant under the Quantum-Si Incorporated 2013 Equity Incentive Plan (“Incentive Plan”)
shall remain outstanding and administered in accordance with the terms and conditions of the Incentive Plan and RSU Grant Agreement.


 


4.             Termination. Either party may terminate this Agreement for any reason upon giving thirty (30) days’ advance
notice of such termination. In the event of such termination of this Agreement, the Company’s only obligation will be to pay Dr.
Rothberg any earned but unpaid Services Fee as of the termination date. Notwithstanding the foregoing, Dr. Rothberg’s entitlements
under Sections 3(c) of this Agreement will survive the termination of this Agreement.


 


5.             Restrictive
Covenants. Dr. Rothberg hereby reaffirms and agrees to comply with the policies and procedures of the Company and its affiliates
for protecting confidential information and will never disclose to any person (except as required by applicable law or for the proper
performance of his duties and responsibilities to the Company and its affiliates), or use for his own benefit or gain, any confidential
information obtained by Dr. Rothberg incident to his association with the Company or any of its affiliates.


 


6.             Conflicts with this Agreement. Dr. Rothberg represents and warrants that he is not under any pre-existing obligation
in conflict or in any way inconsistent with the provisions of this Agreement. Dr. Rothberg represents and warrants that Dr. Rothberg’s
performance of all the terms of this Agreement will not breach any agreement to keep in confidence proprietary information acquired by
Dr. Rothberg in confidence or in trust prior to commencement of this Agreement. Dr. Rothberg warrants that Dr. Rothberg has the right
to disclose and/or or use all ideas, processes, techniques and other information, if any, which Dr. Rothberg has gained from third parties,
and which Dr. Rothberg discloses to the Company or uses in the course of performance of this Agreement, without liability to such third
parties. Notwithstanding the foregoing, Dr. Rothberg agrees that he will not bundle with or incorporate into any deliveries provided to
the Company herewith any third party products, ideas, processes, or other techniques, without the express, written prior approval of the
Company. Dr. Rothberg represents and warrants that he has not granted and will not grant any rights or licenses to any intellectual property
or technology that would conflict with his obligations under this Agreement. Dr. Rothberg will not knowingly infringe upon any copyright,
patent, trade secret or other property right of any former client, employer or third party in the performance of the Services required
by this Agreement.


 


7.             Section
409A. This Agreement is intended to comply with, or be exempt from, the requirements of Section 409A of the Internal Revenue
Code of 1986, as amended, and shall be construed consistent with such intent. Notwithstanding the foregoing, in no event shall the
Company have any liability relating to the failure or alleged failure of any payment or benefit under this Agreement to comply with,
or be exempt from, the requirements of Section 409A.


 






    2 


     


    

 


8.             Miscellaneous.


 


(a)          Entire
Agreement. This Agreement constitutes the sole agreement of the parties and supersedes all oral negotiations and prior writings
with respect to the subject matter hereof.


 


(b)          Amendments and Waivers.  Any term of this Agreement may be amended or waived only with the written consent of the
parties.


 


(c)          Choice
of Law. The validity, interpretation, construction and performance of this Agreement will be governed by the laws of the State
of Connecticut, without giving effect to the principles of conflict of laws.


 


(d)          Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, such
portion will be deemed to be modified or altered to the extent necessary to conform thereto or, if that is not possible, to be omitted
from this Agreement. The invalidity of any such portion will not affect the force, effect, and validity of the remaining portion hereof.


 


(e)          Counterparts. This Agreement may be executed in counterparts, each of which will be deemed an original, but all of
which together will constitute one and the same instrument.


 


(f)           Successors.
This Agreement is personal to Dr. Rothberg and, without the prior written consent of the Company, will not be assignable by Dr. Rothberg
otherwise than by will or the laws of descent and distribution. This Agreement will inure to the benefit of and be enforceable by Dr.
Rothberg’s legal representatives. This Agreement will inure to the benefit of and be binding upon the Company and its successors
and assigns. As used in this Agreement, “the Company” will mean both the Company as defined above and any such successor
that assumes and agrees to perform this Agreement, by operation of law or otherwise.


 


(g)          Advice
of Counsel. EACH PARTY ACKNOWLEDGES THAT, IN EXECUTING THIS AGREEMENT, SUCH PARTY HAS HAD THE OPPORTUNITY TO SEEK THE ADVICE
OF INDEPENDENT LEGAL COUNSEL, AND HAS READ AND UNDERSTOOD ALL OF THE TERMS AND PROVISIONS OF THIS AGREEMENT. THIS AGREEMENT SHALL NOT
BE CONSTRUED AGAINST ANY PARTY BY REASON OF THE DRAFTING OR PREPARATION HEREOF.


 


[Remainder of page intentionally left blank.]


 






    3 


     


    

 


This Agreement has been executed
as a sealed instrument by the Company, by its duly authorized representative and by Dr. Rothberg.


 


	 	QUANTUM-SI INCORPORATED
	 	 	 
	 	By: 	/s/ John Stark
	 	 	 
	 	Name:	John Stark
	 	 	 
	 	Title:	Chief Executive Officer



 


[Signature Page to Executive Chairman Agreement]


 






     


     


    

 


This Agreement has been executed
as a sealed instrument by the Company, by its duly authorized representative and by Dr. Rothberg.


 


	 	JONATHAN ROTHBERG, PH.D.
	 	 
	 	/s/Jonathan Rothberg
	 	Signature	 
	 	 	 
	 	Address:	                              



 


[Signature Page to Executive Chairman Agreement]